Key Takeaway
AOD-9604 vs Tesamorelin comparison. Fat-loss peptide vs Growth hormone secretagogue. When to use each and how they differ.
Quick Answer: AOD-9604 vs Tesamorelin compares a fat-loss peptide with a growth hormone secretagogue. AOD-9604 is used for lipolysis stimulation. Tesamorelin is used for gh stimulation, visceral fat reduction. These compounds serve different purposes and your choice depends on your primary health goal. They can often be used together since they work through independent mechanisms .
Head-to-Head Comparison
| Factor | AOD-9604 | Tesamorelin |
|---|---|---|
| Category | Fat-loss peptide | Growth hormone secretagogue |
| Primary role | Lipolysis stimulation | GH stimulation, visceral fat reduction |
| Mechanism | GH fragment-mediated fat oxidation | GHRH receptor activation, pulsatile GH release |
| Best for | Stubborn fat reduction, body composition | Visceral fat reduction, body composition, lipodystrophy |
| Administration | SC injection daily | SC injection daily |
| Evidence | Preclinical + limited clinical | FDA-approved for HIV lipodystrophy |
When to Choose AOD-9604
- Stubborn fat reduction is your primary goal
- You want lipolysis stimulation
- Stubborn fat reduction, body composition are your focus areas
When to Choose Tesamorelin
- Visceral fat reduction is your primary goal
- You want gh stimulation, visceral fat reduction
- Visceral fat reduction, body composition, lipodystrophy are your focus areas
Can You Use Both?
Yes. AOD-9604 and Tesamorelin work through independent mechanisms and don't interfere with each other. They can be combined when your health goals span both lipolysis stimulation and gh stimulation. Your physician can design a protocol that incorporates both compounds with appropriate timing and dosing.
From the FormBlends catalog
AOD-9604
Fat-targeting fragment without growth hormone side effects · From $199/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View AOD-9604 →View data table
| Category | Clinical Interest Score | Detail |
|---|---|---|
| BPC-157 | 88 | Tissue repair and gut healing |
| TB-500 | 82 | Injury recovery |
| Sermorelin | 78 | Growth hormone support |
| Ipamorelin | 75 | Anti-aging and recovery |
| GHK-Cu | 70 | Skin and tissue repair |
Frequently Asked Questions
Which has stronger evidence?
AOD-9604 has preclinical + limited clinical. Tesamorelin has fda-approved for hiv lipodystrophy. The strength of evidence depends on the specific application you're considering.
Which should I start with?
Start with whichever addresses your most pressing health concern. If you need lipolysis stimulation, start with AOD-9604. If you need gh stimulation, start with Tesamorelin. A physician can help you prioritize.
Find Your Optimal Protocol
At FormBlends, our physicians evaluate your health goals and recommend the most effective approach, whether single compounds or strategic combinations.
Disclaimer: This article is for informational purposes only and doesn't constitute medical advice. Always consult with a licensed healthcare provider. Individual results may vary.
Ready when you are
AOD-9604
Fat-targeting fragment without growth hormone side effects · From $199/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View AOD-9604 →